Beta Bionics, Inc. (BBNX) Stock

Beta Bionics, Inc. (BBNX) is a Healthcare stock trading at $13.88 (as of 2026-06-18), with a market capitalization of $554.79M and a trailing P/E of -10.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Beta Bionics, Inc. designs, develops, and commercializes medical device solutions for insulin-requiring people with diabetes. Its main product is the iLet bionic pancreas for type 1 diabetes, and it also develops additional automated insulin delivery and related systems, including collaborations for glucagon formulation and an automated delivery system.

Valuation — source: SEC EDGAR (first-party)
Price$13.88
Market Cap$554.79M
P/E Ratio-10.6
EV / EBITDA-8.2
Price / Book2.39
Price / Sales5.87
DCF Value (model)$-20.85
DCF Upside vs Price-250.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$100.25M
Net Margin-73.0%
Return on Equity-24.5%
Current Ratio10.69
Revenue Growth (YoY)56.6%
EPS Growth (YoY)-47.3%
FCF Growth (YoY)24.1%
Financial Health — source: SEC EDGAR
Altman Z-Score7.86 (safe)
Valuation vs Sector & Industry
Stock P/E-10.6
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-150.6%
vs Industry-133.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($67.59M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOSean T. Saint
Employees352
CountryUS
IPO Date2025-01-30

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • AxoGen, Inc. (AXGN)
  • Enovis Corporation (ENOV)
  • EyePoint Pharmaceuticals, Inc. (EYPT)
  • NovoCure Limited (NVCR)
  • CONMED Corporation (CNMD)
  • IRadimed Corporation (IRMD)
  • KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
  • STAAR Surgical Company (STAA)
BBNX earnings history · BBNX institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.